Showing 1 - 9 results of 9 for search 'Nina Hanke', query time: 0.06s Refine Results
  1. 1
    A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions

    A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions by Denise Türk, Nina Hanke, Thorsten Lehr

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    PBPK-based translation from preclinical species to humans for the full-size IgG therapeutic efalizumab

    PBPK-based translation from preclinical species to humans for the full-size IgG therapeutic efalizumab by Maria Franz, Ravi Kumar Jairam, Lars Kuepfer, Nina Hanke

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Physiologically based pharmacokinetic models for systemic disposition of protein therapeutics in rabbits

    Physiologically based pharmacokinetic models for systemic disposition of protein therapeutics in rabbits by Ravi Kumar Jairam, Maria Franz, Nina Hanke, Lars Kuepfer

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients

    Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients by Nina Hanke, Claudia Kunz, Meinolf Thiemann, Harald Fricke, Thorsten Lehr

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network

    Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network by Fatima Zahra Marok, Laura Maria Fuhr, Nina Hanke, Dominik Selzer, Thorsten Lehr

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach

    Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach by Laura Maria Fuhr, Fatima Zahra Marok, Nina Hanke, Dominik Selzer, Thorsten Lehr

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions

    Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions by Simeon Rüdesheim, Jan-Georg Wojtyniak, Dominik Selzer, Nina Hanke, Felix Mahfoud, Matthias Schwab, Thorsten Lehr

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug-Drug Interaction Studies

    A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug-Drug Interaction Studies by Nina Hanke, Denise Türk, Dominik Selzer, Sabrina Wiebe, Éric Fernandez, Peter Stopfer, Valerie Nock, Thorsten Lehr

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Physiologically‐Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam

    Physiologically‐Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam by Hannah Britz, Nina Hanke, Anke‐Katrin Volz, Olav Spigset, Matthias Schwab, Thomas Eissing, Thomas Wendl, Sebastian Frechen, Thorsten Lehr

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: